0
Abstract: Poster Presentations |

HERPES ZOSTER AFTER LUNG TRANSPLANTATION: INCIDENCE, TIMING, AND OUTCOME FREE TO VIEW

Leonardo Fuks, MD*; David Shitrit, MD; Benjamin D. Fox, MD; Anat Amital, MD; Yael Raviv, MD; Ilana Bakal, RN; Mordechai R. Kramer, MD
Author and Funding Information

Rabin Medical Center, Petach Tiqwa, Israel


Chest


Chest. 2008;134(4_MeetingAbstracts):p47002. doi:10.1378/chest.134.4_MeetingAbstracts.p47002
Text Size: A A A
Published online

Abstract

PURPOSE: Herpes Zoster infection is a common complication affecting lung transplant recipients. Few studies however, have been published with conflicting results.We determined the incidence and clinical characteristics of herpes zoster after lung transplantation.

METHODS: We retrospectively reviewed all adult lung transplants performed at our institution between January 2001 and December 2007. Clinical characteristics of herpes zoster and potential risk factors associated with herpes zoster were assessed.

RESULTS: One hundred ninety eight lung transplant recipients were included in the analysis. Median time of follow-up was 34 months (range 1 to 85 months). Twenty three episodes of herpes zoster occurred in 23 patients. Four of the 23 (17%) patients had disseminated cutaneous infection and one had visceral involvement. No recurrence of herpes zoster was seen. Post-herpetic neuralgia was detected in 26% of cases. Anti-viral prophylaxis, primarily for cytomegalovirus (CMV), was protective (while on prophylaxis) against herpes zoster. After treatment with RATG there was an increase in the incidence of HZ.

CONCLUSION: Herpes Zoster is a common complication after lung transplantation with a peak incidence between 12 and 36 months post-transplant. Preventive strategies would be beneficial for this population.

CLINICAL IMPLICATIONS: HZ is a common complication observed late after lung transplant. The option of continuous therapy in lung transplant recipient with acyclovir to prevent HZ should be studied in a large prospective trial.

DISCLOSURE: Leonardo Fuks, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, October 28, 2008

1:00 PM - 2:15 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543